Life Sciences Investing & Advisory · Since 2006

Grounded in Expertise
Driven by Experience
Proven Value

Since 2006, we have helped life sciences businesses achieve their full potential.

InvestingAdvisory
20+Years Experience
155+Investments & Transactions
8Investment Funds Raised
41Investment Portfolio Exits
About BroadOak

The industry’s most active life sciences–focused boutique financial institution

BroadOak Capital Partners is a life sciences focused, boutique financial institution that provides direct investment through BroadOak Asset Management, and investment banking services through BroadOak Partners, to companies in the life sciences tools, diagnostics, and biopharma services sectors. BroadOak has made investments in more than 90 companies and advised on over 50 successful M&A transactions.

Investing

Growth capital for the development and acceleration of successful businesses.

Learn More

Advisory Services

Services to help management teams optimize sale processes, mergers, acquisitions, and financing.

Learn More

Our Expertise

BroadOak advises and invests in life sciences tools, diagnostics, and services companies.

01

Life Sciences Tools

Market Size: $130B

Instruments and consumables used in therapeutic discovery and development

02

Diagnostics

Market Size: $50B

Diagnostic tests, test components, and instruments for analysis

03

Biopharma Services

Market Size: $100B

Research, development, and manufacturing services for biopharma companies

Our Portfolio & Advisory Clients

View Portfolio